Liselotte Larsson
Chief Operating Officer at CANTARGIA AB
Net worth: 21 326 $ as of 29/04/2024
Network origin in Liselotte Larsson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
26
| Public Company | Pharmaceuticals: Major | 26 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Liselotte Larsson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ACTIVE BIOTECH AB | Biotechnology | Chief Executive Officer Investor Relations Contact Corporate Officer/Principal | |
| RAYSEARCH LABORATORIES AB | Packaged Software | Director of Finance/CFO | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Stockholm | College/University | Undergraduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
| Royal Institute of Technology | College/University | Graduate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree | |
| ENSIMAG | College/University | Graduate Degree | |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
| BIOARCTIC AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Life Science Ventures
 Life Science Ventures Investment ManagersFinance Life Science Ventures provides financial advice. | Investment Managers | Corporate Officer/Principal | |
| Kabi Pharmacia | President Corporate Officer/Principal | ||
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Sunstone LSV General Partner I ApS | Corporate Officer/Principal | ||
Extenda AB
 Extenda AB Information Technology ServicesTechnology Services Extenda AB develops point-of-sale technology (POS) solutions. Its product suite include transaction engine, selfscan, mobile POS, and self checkout. The firm also offers support, service and maintenance, and catalogue services. The company was founded by Peter Carlman in 1982 and is headquartered in Stockholm, Sweden. | Information Technology Services | Director of Finance/CFO | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Investor Relations Contact | |
| QLUCORE AB | Packaged Software | Founder | |
| FOI - Totalförsvarets forskningsinstitut | Director/Board Member | ||
FBC Device ApS
 FBC Device ApS Medical SpecialtiesHealth Technology FBC Device ApS provides spinal implants for the treatment of degenerative disc disease. Its products include Statur-L. The firm develops and manufactures healthcare equipment that helps in the placement of spine in correct position after an implant surgery. The company was founded by Finn Bjarke Christensen in 2005 and is headquartered in Risskov, Denmark. | Medical Specialties | Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| The International Venture Club | Corporate Officer/Principal | ||
| Sunstone LSV Management A/S | Director/Board Member | ||
| Sunstone LSV General Partner BI ApS | Corporate Officer/Principal | ||
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member | |
| Oncopeptides Incentive AB | Director/Board Member | ||
| Sciencecap Stockholm AB | Director/Board Member | ||
Sunstone Life Science Ventures A/S
 Sunstone Life Science Ventures A/S Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone Life Science Ventures A/S is a Danish company that provides investment services. The company is based in Copenhagen, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
ReWind Therapeutics NV
 ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier. | Pharmaceuticals: Major | Director/Board Member | |
Parsimoneous Holding ApS
 Parsimoneous Holding ApS Financial ConglomeratesFinance Parsimoneous Holding ApS functions as an investment holding Danish company. The private company is based in Gentofte, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Latentix ApS
 Latentix ApS Information Technology ServicesTechnology Services Latentix ApS provides custom computer programming services. The private company is based in Frederiksberg, Denmark. | Information Technology Services | Corporate Officer/Principal | |
Sunstone Lsv & Co. Invest Ill Holding Aps
 Sunstone Lsv & Co. Invest Ill Holding Aps Financial ConglomeratesFinance Sunstone Lsv & Co. The private company is based in Copenhagen, Denmark. Invest Ill Holding Aps functions as an investment holding Danish company. | Financial Conglomerates | Chief Executive Officer | |
| Asbjørn Andersson ApS | Chief Executive Officer | ||
| Lisa Martin-Löf Konsultbyrå AB | Director/Board Member | ||
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Medical/Nursing Services | Director of Finance/CFO | |
| COEGIN PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
Vakona AB
 Vakona AB BiotechnologyHealth Technology Vakona is a Swedish company that is developing a new biological drug for the treatment of acne. The drug is based on a bacterial enzyme and has the potential to significantly reduce treatment time and side effects such as skin irritation. The company's research is based on over a decade of work by Dr. Oleg Alexeyev and aims to provide an alternative to the long-term inefficacy of current acne therapies that rely on antibiotics. The company was founded by Oleg Alexeyev and has CEOs Mats Olof Strömqvist and Gabriella Persson. | Biotechnology | Chief Executive Officer | |
| Neodos AB | Director/Board Member |
Statistics
International
| Sweden | 31 |
| Denmark | 17 |
| Belgium | 3 |
| France | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 21 |
| Consumer Services | 8 |
| Technology Services | 5 |
| Finance | 5 |
| Commercial Services | 4 |
Operational
| Director/Board Member | 113 |
| Corporate Officer/Principal | 56 |
| Chairman | 38 |
| Chief Executive Officer | 30 |
| Independent Dir/Board Member | 29 |
Most connected contacts
- Stock Market
- Insiders
- Liselotte Larsson
- Company connections
